<b>Background:</b> Glucose-transporter-1 deficiency syndrome (GLUT1-DS), due to <i>SLC2A1</i> gene mutation, is characterized by early-onset seizures, which are often drug-resistant, developmental delay, and hypotonia. This evidence concerns the gene SLC2A1 and Dravet syndrome.